$24.99
1.75% today
Nasdaq, Dec 03, 07:05 pm CET
ISIN
US74019L1070
Symbol
PRPO

Precipio, Inc. Stock price

$24.56
+4.59 22.98% 1M
+13.66 125.29% 6M
+19.02 343.34% YTD
+18.60 312.08% 1Y
+9.02 58.06% 3Y
-19.24 43.93% 5Y
-9,515.44 99.74% 10Y
-118,775.44 99.98% 20Y
Nasdaq, Closing price Tue, Dec 02 2025
+1.99 8.82%

Key metrics

Basic
Market capitalization
$43.0m
Enterprise Value
$41.8m
Net debt
positive
Cash
$2.3m
Shares outstanding
1.8m
Valuation (TTM | estimate)
P/E
negative | -
P/S
1.9 | -
EV/Sales
1.8 | -
EV/FCF
70.9
P/B
3.1
Financial Health
Equity Ratio
71.2%
Return on Equity
-35.5%
ROCE
-12.5%
ROIC
-11.9%
Debt/Equity
0.1
Financials (TTM | estimate)
Revenue
$22.8m | -
EBITDA
$-690.0k | -
EBIT
$-2.1m | -
Net Income
$-1.3m | -
Free Cash Flow
$590.0k
Growth (TTM | estimate)
Revenue
31.0% | -
EBITDA
60.1% | -
EBIT
31.0% | -
Net Income
58.3% | -
Free Cash Flow
345.8%
Margin (TTM | estimate)
Gross
44.8%
EBITDA
-3.0% | -
EBIT
-9.1%
Net
-5.5% | -
Free Cash Flow
2.6%
More
EPS
$-0.8
FCF per Share
$0.3
Short interest
0.1%
Employees
57
Rev per Employee
$330.0k
Show more

Is Precipio, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,097 stocks worldwide.

Precipio, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Precipio, Inc. forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a Precipio, Inc. forecast:

Buy
86%
Hold
14%

Financial data from Precipio, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
23 23
31% 31%
100%
- Direct Costs 13 13
20% 20%
55%
10 10
47% 47%
45%
- Selling and Administrative Expenses - -
-
-
- Research and Development Expense - -
-
-
-0.69 -0.69
60% 60%
-3%
- Depreciation and Amortization 1.40 1.40
9% 9%
6%
EBIT (Operating Income) EBIT -2.08 -2.08
31% 31%
-9%
Net Profit -1.25 -1.25
58% 58%
-5%

In millions USD.

Don't miss a Thing! We will send you all news about Precipio, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Precipio, Inc. Stock News

Neutral
Seeking Alpha
16 days ago
Precipio, Inc. ( PRPO ) Q3 2025 Earnings Call November 17, 2025 5:00 PM EST Company Participants Ilan Danieli - Founder, President, CEO & Director Presentation Operator Welcome to the Precipio Third Quarter 2025 Shareholder Update Conference Call. [Operator Instructions] Please note that the conference is being recorded.
Neutral
GlobeNewsWire
19 days ago
Over $450,000 Adjusted EBITDA and $275,000 positive operating cash flow for the quarter Over $450,000 Adjusted EBITDA and $275,000 positive operating cash flow for the quarter
Neutral
GlobeNewsWire
29 days ago
NEW HAVEN, Conn., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Q3-2025 corporate update call on November 17th, 2025 at 5:00 PM ET.
More Precipio, Inc. News

Company Profile

Precipio, Inc. is a cancer diagnostics company, which engages in the development and provision of a platform designed to eradicate the problem of misdiagnosis. Its products include MX-ICP, HemeScreen, and IV-Cell, and services include primary diagnostic, SmartPath, SmartGen, HRM kits and ICP liquid biopsy testing. The company was founded on March 6, 1997 and is headquartered in New Haven, CT.

Head office United States
CEO Ilan Danieli
Employees 57
Founded 1997
Website www.precipiodx.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today